ArticleEuropean journal of medical research2025
The earlier metabolic bariatric surgery is performed, the better expected clinical benefit beyond weight loss: a short-term follow-up study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of polyethylene glycol loxenatide on weight loss in super-obese patients with type 2 diabetes: a randomized controlled trial.Frontiers in endocrinology · 2026Trial
- The Impact of Vertical Sleeve Gastrectomy on Behavioral and Reward-Related Outcomes.Brain and behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a global public health challenge, which is strongly associated with dozens of diseases. Metabolic bariatric surgery is recognized as a long-term and effective treatment for obesity and obesity-related medical conditions. The aim of this study is to investigate the relationship between the timing of metabolic bariatric surgery and postoperative weight loss along with the clinical remission of obesity-related medical conditions.
methodsThis study examined 143 patients with obesity who underwent laparoscopic sleeve gastrectomy (LSG) from Feb 2015 to Feb 2022. The median time from meeting the criteria for metabolic bariatric surgery to finally undergoing metabolic bariatric surgery for all participants was 5.75 years. Based on this, the participants were divided into two groups: the early operation group (persons with a duration of obesity prior to surgery of less than 5 years) and the late operation group (those with the duration of longer than 5 years). Weight metrics, biochemical indicators and improvements in obesity-related medical conditions of both groups were analyzed before the operation and 1 year after the operation.
resultsAll patients completed a postoperative follow-up of at least 1 year. There was no significant variation in weight loss, TWL% (P ≥ 0.05) between the early operation and late operation groups. Whereas patients in the early operation group had better improvements in obesity-related medical conditions 1 year after surgery (P < 0.05). Furthermore, the early operation group showed a more pronounced decrease in related metabolic indices, such as fasting blood glucose and triglyceride (P < 0.01).
conclusionsPatients undergoing metabolic bariatric surgery experienced significant weight reduction. Notably, those in the early operation group exhibited better improvement in obesity-related medical conditions and related metabolic indices post-operation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.